Navigation Links
Ceragenix Announces Results from Phase IV Study of EpiCeram Meet,All Primary and Secondary Endpoints

qualified personnel. The aforementioned factors do not represent an all inclusive list. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained in this press release. In particular, important factors that could cause actual results to differ materially from the company's forward-looking statements include general economic factors, business strategies, the state of capital markets, regulatory conditions, and other factors not currently known to the company, may be significant, now or in the future, and these factors may affect the company to a greater extent than indicated. All forward-looking statements attributable to the company or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements set forth in this press release and in other documents that the company files from time to time with the Securities and Exchange Commission including its Annual Report on Form 10-KSB for the year ended December 31, 2006, Quarterly Reports on Form 10-QSB and Current Reports on Form 8-KSB to be filed in 2007. Except as required by law, the company does not undertake any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Contact

Ceragenix
Steven S. Porter, 720-946-6440
or
CEOcast, Inc.
Andrew Hellman, 212-732-4300


'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
2. Ceragenix Announces New Publication of Scientific Research on Ceragenin Technology
3. Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm Formation in 21 Day Study
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:7/23/2014)... 2014 PositiveID Corp. (OTCQB: PSID), based in ... an emerging player in the bio-threat detection market, ... and rapid medical testing. The Company,s proprietary airborne ... Networked Detector), was developed under contract with the ... Technology directorate, and $30 million of contract funding. ...
(Date:7/23/2014)... Pa. , July 23, 2014 /PRNewswire/ ... today announced successful results from its randomized, ... in women with biopsy-proven cervical intraepithelial neoplasia ... types 16 or 18. Treatment with VGX-3100, ... of CIN2/3 to CIN1 or no disease, ...
(Date:7/23/2014)... -- Nearly 8,000 attendees will converge in Washington ... Conference (RBC), taking place July 23-26 at the Gaylord ... pharmacists to "Lead Change" in the pharmacy profession, in ... their future. "RBC is the perfect opportunity ... and learn new ways they can lead change in ...
Breaking Medicine Technology:PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6
...  Responding to a need for better post-market surveillance of orthopedic ... Consortium of Orthopaedic Registries in October 2010. As ... Journal of Bone and Joint Surgery , ... for improving the safety of orthopedic devices using outcomes registries ...
... Dec. 21, 2011 Senate Democratic Leader John L. ... and CEO of Walgreens Inc., expressing his dismay about ... drug coverage more affordable for many of the low-income ... Walgreens has administered the program through Express Scripts, ...
Cached Medicine Technology:Unprecedented International Effort Seeks to Improve Safety of Orthopedic Devices 2Unprecedented International Effort Seeks to Improve Safety of Orthopedic Devices 3Unprecedented International Effort Seeks to Improve Safety of Orthopedic Devices 4
(Date:7/23/2014)... 2014 The next episode of “Extreme ... Wis. who was physically fit through childhood and adolescence. ... made the heart-wrenching decision to give her son up ... past 18 years, and she punished herself by overeating, ... a unique, non-competitive approach to weight loss transformations, “Extreme ...
(Date:7/23/2014)... 23, 2014 Home Care Assistance ... for seniors, is proud to announce the next installment ... in a wide range of health and wellness-related fields. ... and award-winning author Nancy Kriseman, and will cover the ... prevent burnout by becoming more self-aware. In particular, Nancy ...
(Date:7/23/2014)... or itchy skin lesions could be a warning sign ... multiple lesions that are suspicious looking, and those that ... non-melanoma skin cancers," study author Dr. Gil Yosipovitch, chairman ... in a Temple University Health System news release. ... who were confirmed to have skin cancer lesions between ...
(Date:7/23/2014)... body of research suggesting a safe and effective ... breast cancer, with fewer detrimental side effects and ... The study will be published in final format ... and Endocrinology . , Breast cancer is the ... United States. Approximately 70% of breast cancers are ...
(Date:7/23/2014)... The National Institute of Biomedical Imaging and Bioengineering ... Symposium on July 30, 2014 on the NIH campus. ... investigators covering a wide breadth of NIBIB-funded research. ... Cohen, Harvard, Engineering Microbial Rhodopsins as Optical Voltage Sensor, ... Fluorescently Labeled Probes for Nerve Imaging ...
Breaking Medicine News(10 mins):Health News:“Extreme Weight Loss”: Cassie’s journey begins at the University of Colorado Anschutz Health and Wellness Center 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3Health News:Painful, Itchy Patches Could Be Sign of Skin Cancer 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5
... Dec. 15 Today, the U.S. Food,and Drug Administration ... along with diet to help lower triglycerides,and LDL cholesterol, ... TRILIPIX is the first and only fibrate to ... In certain patients, treatment guidelines,recommend the combination of a ...
... Matthew L. Myers President, Campaign for Tobacco-Free Kids , ... U.S. Supreme Court today handed down a major victory for ... state consumer protection laws to sue Philip Morris and other ... Today,s ruling poses a significant legal threat to the ...
... Controlling Costs, Improving Quality as Health Care Reform Debate Centers on ... Dec. 15 House Ways and Means Health Subcommittee Chairman ... counsel to Sen. Max Baucus, will join health care expert and ... Future co-director Roger Hickey on a conference call with ...
... Dec. 15 Following is a statement from Michael ... in regards to its financial exposure with Madoff Securities: ... Health System,s financial exposure with Madoff Securities is limited to ... who stipulated that the funds be invested with Madoff. The ...
... Dec. 15 The American Red Cross sheltered hundreds of people ... Northeast. Working with local partners, Red Cross chapters opened shelters in ... , "Unfortunately, ice storms are par for ... is always ready to give people a safe and warm place ...
... Lab study showed it had effect on 60% Of malignant ... produced by the oncogene MYC can stop the spread of ... that has the potential to help cause cancer. , In ... overly active. This causes the ovarian cells to produce excessive ...
Cached Medicine News:Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 2Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 3Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 4Health News:U.S. Supreme Court Ruling Allowing Light Cigarette Lawsuits Is Victory for Consumers and Health 2Health News:U.S. Supreme Court Ruling Allowing Light Cigarette Lawsuits Is Victory for Consumers and Health 3Health News:North Shore-LIJ Health System Exposure With Madoff Securities Limited to $5.7M 2Health News:Red Cross Shelters Hundreds as Severe Weather Hits Northeast 2
The KMedic Jet Wire Twister is designed to provide fast, smooth and even twisting of soft wire, saving time in the O.R. Now available for the first time in stainless steel. Suitable for the entire ra...
Lead filled and faced bone mallet used to exert force on osteotomes, chisels, and gouges....
Slightly curved Periosteal elevator....
Straight chisel for scoring, cutting, scraping, cleaning and sculpting bone....
Medicine Products: